SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 170 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $352,000 | +47.9% | 19,645 | -2.8% | 0.00% | – |
| Q3 2017 | $238,000 | +13.9% | 20,212 | +1.1% | 0.00% | – |
| Q2 2017 | $209,000 | -1.4% | 19,983 | +4.1% | 0.00% | – |
| Q1 2017 | $212,000 | -9.8% | 19,193 | +10.9% | 0.00% | – |
| Q4 2016 | $235,000 | +9.3% | 17,309 | -1.1% | 0.00% | – |
| Q3 2016 | $215,000 | +10.3% | 17,510 | -1.8% | 0.00% | – |
| Q2 2016 | $195,000 | +10.2% | 17,833 | +4.6% | 0.00% | – |
| Q1 2016 | $177,000 | -39.8% | 17,050 | +0.5% | 0.00% | – |
| Q4 2015 | $294,000 | -11.4% | 16,969 | +1.7% | 0.00% | – |
| Q3 2015 | $332,000 | +20.3% | 16,688 | -0.9% | 0.00% | – |
| Q2 2015 | $276,000 | +35.3% | 16,845 | +28.8% | 0.00% | – |
| Q1 2015 | $204,000 | +11.5% | 13,079 | +2.0% | 0.00% | – |
| Q4 2014 | $183,000 | +357.5% | 12,824 | +106.0% | 0.00% | – |
| Q3 2014 | $40,000 | +233.3% | 6,224 | +246.4% | 0.00% | – |
| Q2 2014 | $12,000 | -7.7% | 1,797 | 0.0% | 0.00% | – |
| Q1 2014 | $13,000 | -23.5% | 1,797 | 0.0% | 0.00% | – |
| Q4 2013 | $17,000 | +54.5% | 1,797 | 0.0% | 0.00% | – |
| Q3 2013 | $11,000 | -8.3% | 1,797 | 0.0% | 0.00% | – |
| Q2 2013 | $12,000 | – | 1,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 311 | $6,000 | 0.00% |
| NOMURA HOLDINGS INC | 33,500 | $599,000 | 0.00% |
| IFP Advisors, Inc | 384 | $7,000 | 0.00% |
| GLENMEDE TRUST CO NA | 461 | $8,000 | 0.00% |